These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Gordon JH; Diamond BI Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695 [TBL] [Abstract][Full Text] [Related]
12. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Bishnoi M; Kumar A; Chopra K; Kulkarni SK Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557 [TBL] [Abstract][Full Text] [Related]
13. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862 [TBL] [Abstract][Full Text] [Related]
14. Management of tardive dyskinesia: current update. Simpson GM; Pi EH; Sramek JJ Drugs; 1982 May; 23(5):381-93. PubMed ID: 7047137 [TBL] [Abstract][Full Text] [Related]
15. Treatment of tardive dyskinesia with levetiracetam in a transplant patient. Zivković SA; Costa G; Bond G; Abu-Elmagd KM Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990 [TBL] [Abstract][Full Text] [Related]
16. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768 [TBL] [Abstract][Full Text] [Related]
17. The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia. Rosengarten H; Bartoszyk GD; Quartermain D; Lin Y Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):273-9. PubMed ID: 16229932 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Lundblad M; Usiello A; Carta M; Håkansson K; Fisone G; Cenci MA Exp Neurol; 2005 Jul; 194(1):66-75. PubMed ID: 15899244 [TBL] [Abstract][Full Text] [Related]